Carisma Therapeutics (CARM) - 2020 Q3 - Earnings Call Transcript

Sesen Bio, Inc. (SESN) Q3 2020 Earnings Conference Call November 9, 2020 8:00 AM ET Company Participants Erin Clark - Vice President of Investor Relations Thomas Cannell - President and Chief Executive Officer Chad Myskiw - Strategic Planning, CMC Monica Forbes - Chief Financial Officer Conference Call Participants John Newman - Canaccord Genuity Operator Ladies and gentlemen, thank you for standing by and welcome to the Sesen Bio Third Quarter 2020 Business Update Conference Call. At this time, all partici ...